Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Idebenone in DMD Patients (SIDEROS-E)
NCT03603288Phase 3Terminated
- Sponsor
- Santhera Pharmaceuticals
- Start
- Jul 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of idebenone in Duchenne muscular dystrophy (DMD), sponsored by Santhera Pharmaceuticals. Started Jul 2018; status: terminated.
02
Drugs
idebenone
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT03603288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03603288.